Leslie221 Posted July 5, 2005 Share Posted July 5, 2005 Just saw this article and thought some of you with stage i might find it interesting. Best wishes, Leslie Chemoprevention study for non-small cell lung cancer Source: (National Cancer Institute) Wednesday, June 15, 2005 NCI Featured Trial Phase III Randomized Chemoprevention Study of Selenium in Participants with Previously Resected Stage I Non-Small Cell Lung Cancer (ECOG-5597). See the protocol summary. What do the researchers want to learn in this trial? Researchers are investigating selenium as a chemoprevention agent against development of secondary lung tumors. "With stage I non-small cell lung cancers that have been treated successfully with surgery, the more likely risk is development of a second tumor rather than recurrence of the original tumor," said lead investigator Daniel David Karp, of the Eastern Cooperative Oncology Group. "So we are interested in seeing if selenium will be effective in preventing the growth of new tumors in patients who have undergone curative surgery for non-small cell lung cancer." In a previous study, selenium appeared to cause decreases in both prostate and lung cancer, but those results were not statistically validated. Subsequent studies, including this one, seek to validate those observations, Karp said. Why Is This Trial Important? Lung cancer kills more Americans than any other cancer. Surgical removal of tumors is the preferred treatment for non-small cell lung cancer. However, the incidence of a second tumor developing in patients who have been treated surgically for early-stage non-small cell lung cancer is about 20-30 percent. Who Can Join This Trial? Researchers seek to enroll 1,960 patients 18 years of age and older who have had stage I non-small cell lung cancer completely removed by surgery. See the full list of eligibility criteria for this trial at NCI's clinical trials web page. Where Is This Trial Taking Place? Study sites in the United States and elsewhere are enrolling patients in this trial. See the list of study sites. Principal Investigators Dr. Daniel David Karp, Eastern Cooperative Oncology Group; Dr. Michael Liptay, American College of Surgeons Oncology Group; Dr. Omer Kucuk, Southwest Oncology Group; Dr. Randolph Marks, North Central Cancer Treatment Group; Dr. Michael R. Johnston, National Cancer Institute of Canada; Dr. Gerald H. Clamon, Cancer and Leukemia Group B; Dr. Steven Belinsky, Lovelace Respiratory Research Institute Who to Contact See the list of study contacts at or call the "Featured Clinical Trial" columns at NCI's Web site. Go to this website for more info. http://www.cancer.gov/clinicaltrials/ECOG-5597 Quote Link to comment Share on other sites More sharing options...
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.